108 related articles for article (PubMed ID: 2569781)
1. Subcellular distribution of titanium in the liver after treatment with the antitumor agent titanocene dichloride. A study using electron spectroscopic imaging.
Köpf-Maier P; Martin R
Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 57(4):213-22. PubMed ID: 2569781
[TBL] [Abstract][Full Text] [Related]
2. Intracellular localization of titanium within xenografted sensitive human tumors after treatment with the antitumor agent titanocene dichloride.
Köpf-Maier P
J Struct Biol; 1990; 105(1-3):35-45. PubMed ID: 2100149
[TBL] [Abstract][Full Text] [Related]
3. Electron-spectroscopic imaging--a method for analysing the distribution of light elements in mammalian cells and tissues.
Köpf-Maier P
Acta Histochem; 1991; 91(1):25-37. PubMed ID: 1801512
[TBL] [Abstract][Full Text] [Related]
4. Histologic and ultrastructural alterations of a xenografted human colon adenocarcinoma after treatment with titanocene dichloride.
Köpf-Maier P
J Cancer Res Clin Oncol; 1988; 114(3):250-8. PubMed ID: 3384842
[TBL] [Abstract][Full Text] [Related]
5. Anti-proliferative activity and mechanism of action of titanocene dichloride.
Christodoulou CV; Eliopoulos AG; Young LS; Hodgkins L; Ferry DR; Kerr DJ
Br J Cancer; 1998 Jun; 77(12):2088-97. PubMed ID: 9649119
[TBL] [Abstract][Full Text] [Related]
6. The phosphorus content of lysosomes in hepatocytes and Kupffer cells. A study using electron-spectroscopic imaging.
Köpf-Maier P
Acta Anat (Basel); 1990; 139(2):164-72. PubMed ID: 2288203
[TBL] [Abstract][Full Text] [Related]
7. Organ distribution and pharmacokinetics of titanium after treatment with titanocene dichloride.
Köpf-Maier P; Brauchle U; Henssler A
Toxicology; 1988 Oct; 51(2-3):291-8. PubMed ID: 3176032
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
Köpf-Maier P
Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
[TBL] [Abstract][Full Text] [Related]
9. Intracellular distribution of titanium after treatment with the antitumor agent titanocene dichloride: on electron energy loss spectroscopic study.
Köpf-Maier P; Krahl D
Naturwissenschaften; 1981 May; 68(5):273-4. PubMed ID: 7242687
[No Abstract] [Full Text] [Related]
10. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
[TBL] [Abstract][Full Text] [Related]
11. Transplacental passage of titanium after treatment with titanocene dichloride.
Köpf-Maier P; Brauchle U; Heussler A
Toxicology; 1988 Mar; 48(3):253-60. PubMed ID: 3344525
[TBL] [Abstract][Full Text] [Related]
12. Tumor inhibition by metallocenes: ultrastructural localization of titanium and vanadium in treated tumor cells by electron energy loss spectroscopy.
Köpf-Maier P; Krahl D
Chem Biol Interact; 1983 Jun; 44(3):317-28. PubMed ID: 6872095
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Titanocene Dichloride (CAS No. 1271-19-8) in F344/N Rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1991 Sep; 399():1-182. PubMed ID: 12637960
[TBL] [Abstract][Full Text] [Related]
14. A controlled release system of titanocene dichloride by electrospun fiber and its antitumor activity in vitro.
Chen P; Wu QS; Ding YP; Chu M; Huang ZM; Hu W
Eur J Pharm Biopharm; 2010 Nov; 76(3):413-20. PubMed ID: 20854905
[TBL] [Abstract][Full Text] [Related]
15. Study of the cytotoxicity and particle action in human cancer cells of titanocene-functionalized materials with potential application against tumors.
García-Peñas A; Gómez-Ruiz S; Pérez-Quintanilla D; Paschke R; Sierra I; Prashar S; del Hierro I; Kaluđerović GN
J Inorg Biochem; 2012 Jan; 106(1):100-10. PubMed ID: 22112846
[TBL] [Abstract][Full Text] [Related]
16. Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors.
Korfel A; Scheulen ME; Schmoll HJ; Gründel O; Harstrick A; Knoche M; Fels LM; Skorzec M; Bach F; Baumgart J; Sass G; Seeber S; Thiel E; Berdel WE
Clin Cancer Res; 1998 Nov; 4(11):2701-8. PubMed ID: 9829732
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor activity of Titanocene Y in xenografted Caki-1 tumors in mice.
Fichtner I; Pampillón C; Sweeney NJ; Strohfeldt K; Tacke M
Anticancer Drugs; 2006 Mar; 17(3):333-6. PubMed ID: 16520662
[TBL] [Abstract][Full Text] [Related]
18. Localization of cathepsin D in rat liver. Immunocytochemical study using post-embedding immunoenzyme and protein A-gold techniques.
Yokota S; Tsuji H; Kato K
Histochemistry; 1985; 82(2):141-8. PubMed ID: 3888929
[TBL] [Abstract][Full Text] [Related]
19. Liver ultrastructure and a new cell type in the Japanese newt, Cynops pyrrhogaster.
Osman AH; Pfeiffer CJ; Asashima M
Eur J Morphol; 1991; 29(4):255-70. PubMed ID: 1815727
[TBL] [Abstract][Full Text] [Related]
20. The blood-testis barrier as a target of some chemotherapeutic agents.
Pereira ML; Garcia e Costa F
Chemotherapy; 2007; 53(6):446-8. PubMed ID: 17957098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
